Chiara Traini

Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade

Interstitial Cells: Regulators of Smooth Muscle Function

Flavonoids as natural phenolic compounds and their role in therapeutics: an overview

Bowel Disorders

Nucleotide signalling during inflammation

Extracellular phosphorylation of the amyloid β‐peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

Structure-based drug screening for G-protein-coupled receptors

A Phenotypic Change But Not Proliferation Underlies Glial Responses in Alzheimer Disease

Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain

The immunology of stroke: from mechanisms to translation

Crystal structure of the µ-opioid receptor bound to a morphinan antagonist

The Amyloid State of Proteins in Human Diseases

Reactive Astrocytes: Production, Function, and Therapeutic Potential

Biophenols pharmacology against the amyloidogenic activity in Alzheimer’s disease

The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease

Purinergic signalling and disorders of the central nervous system

Microglial dysfunction in brain aging and Alzheimer's disease

Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro

Alzheimer's disease

Toxicity of Protein Oligomers Is Rationalized by a Function Combining Size and Surface Hydrophobicity

Interaction of toxic and non-toxic HypF-N oligomers with lipid bilayers investigated at high resolution with atomic force microscopy

Religious Orders Study and Rush Memory and Aging Project

Structure-Based Discovery of Novel Chemotypes for Adenosine A_2AReceptor Antagonists

Update 1 of: Computational Modeling Approaches to Structure–Function Analysis of G Protein-Coupled Receptors

Relation of DASH- and Mediterranean-like dietary patterns to cognitive decline in older persons

Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases

The role of ATP and adenosine in the brain under normoxic and ischemic conditions

Synthesis, ligand–receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists

The Polyphenol Oleuropein Aglycone Protects TgCRND8 Mice against Aß Plaque Pathology

Aβ plaque-associated glial reaction as a determinant of apoptotic neuronal death and cortical gliogenesis: A study in APP mutant mice

Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N

Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a New Scaffold To Develop Potent and Selective Human A₃Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand−Receptor Modeling Studies

Telocytes express PDGFRα in the human gastrointestinal tract